Nuclear Medicine Imaging Agents Market, Global Outlook and Forecast 2023-2029

Report ID: MMG302202 | Category: Medical Devices & Consumables | Pages: 70 | Format: PDF | Published Date: December 08,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3250.00 Multi User-$4225.00

Report Description
View Table of Contents

Report Summary

This research report provides a comprehensive analysis of the Nuclear Medicine Imaging Agents market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Nuclear Medicine Imaging Agents market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Nuclear Medicine Imaging Agents, challenges faced by the industry, and potential opportunities for market players.
The global Nuclear Medicine Imaging Agents market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Nuclear Medicine Imaging Agents market presents opportunities for various stakeholders, including Early Diagnosis, Clinical Stage. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Nuclear Medicine Imaging Agents market. Additionally, the growing consumer demand present avenues for market expansion.
The global Nuclear Medicine Imaging Agents market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the Nuclear Medicine Imaging Agents market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Nuclear Medicine Imaging Agents market.
Market Overview: The report provides a comprehensive overview of the Nuclear Medicine Imaging Agents market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Fluorine 18 Labeling, Carbon 11 Labeling), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Nuclear Medicine Imaging Agents market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Nuclear Medicine Imaging Agents market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Nuclear Medicine Imaging Agents market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Nuclear Medicine Imaging Agents market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Nuclear Medicine Imaging Agents market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Nuclear Medicine Imaging Agents market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Nuclear Medicine Imaging Agents, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Nuclear Medicine Imaging Agents market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Nuclear Medicine Imaging Agents market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Fluorine 18 Labeling
Carbon 11 Labeling
Nitrogen 13 Labeling
Oxygen 15 Labeling
Technetium 99 Labeling
Others
Market segment by Application
Early Diagnosis
Clinical Stage
Treatment Evaluation
Global Nuclear Medicine Imaging Agents Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
GE HealthCare
Bracco Diagnostic
Guerbet
Mallinckrodt
Lantheus
Yantai Dongcheng
Foshan Rui Diao Pharmaceutical
Cardinal Health
Blue Earth Diagnostics
Bayer AG
Abx Advanced Biochemical
Eli Lilly and Company
Jubilant Pharma Limited
Navidea
Outline of Major Chapters:
Chapter 1: Introduces the definition of Nuclear Medicine Imaging Agents, market overview.
Chapter 2: Global Nuclear Medicine Imaging Agents market size in revenue and volume.
Chapter 3: Detailed analysis of Nuclear Medicine Imaging Agents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Nuclear Medicine Imaging Agents in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Nuclear Medicine Imaging Agents capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

1 Introduction to Research & Analysis Reports
    1.1 Nuclear Medicine Imaging Agents Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Nuclear Medicine Imaging Agents Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Nuclear Medicine Imaging Agents Overall Market Size
    2.1 Global Nuclear Medicine Imaging Agents Market Size: 2022 VS 2029
    2.2 Global Nuclear Medicine Imaging Agents Revenue, Prospects & Forecasts: 2018-2029
    2.3 Global Nuclear Medicine Imaging Agents Sales: 2018-2029
3 Company Landscape
    3.1 Top Nuclear Medicine Imaging Agents Players in Global Market
    3.2 Top Global Nuclear Medicine Imaging Agents Companies Ranked by Revenue
    3.3 Global Nuclear Medicine Imaging Agents Revenue by Companies
    3.4 Global Nuclear Medicine Imaging Agents Sales by Companies
    3.5 Global Nuclear Medicine Imaging Agents Price by Manufacturer (2018-2023)
    3.6 Top 3 and Top 5 Nuclear Medicine Imaging Agents Companies in Global Market, by Revenue in 2022
    3.7 Global Manufacturers Nuclear Medicine Imaging Agents Product Type
    3.8 Tier 1, Tier 2 and Tier 3 Nuclear Medicine Imaging Agents Players in Global Market
        3.8.1 List of Global Tier 1 Nuclear Medicine Imaging Agents Companies
        3.8.2 List of Global Tier 2 and Tier 3 Nuclear Medicine Imaging Agents Companies
4 Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Nuclear Medicine Imaging Agents Market Size Markets, 2022 & 2029
        4.1.2 Fluorine 18 Labeling
        4.1.3 Carbon 11 Labeling
        4.1.4 Nitrogen 13 Labeling
        4.1.5 Oxygen 15 Labeling
        4.1.6 Technetium 99 Labeling
        4.1.7 Others
    4.2 By Type - Global Nuclear Medicine Imaging Agents Revenue & Forecasts
        4.2.1 By Type - Global Nuclear Medicine Imaging Agents Revenue, 2018-2023
        4.2.2 By Type - Global Nuclear Medicine Imaging Agents Revenue, 2024-2029
        4.2.3 By Type - Global Nuclear Medicine Imaging Agents Revenue Market Share, 2018-2029
    4.3 By Type - Global Nuclear Medicine Imaging Agents Sales & Forecasts
        4.3.1 By Type - Global Nuclear Medicine Imaging Agents Sales, 2018-2023
        4.3.2 By Type - Global Nuclear Medicine Imaging Agents Sales, 2024-2029
        4.3.3 By Type - Global Nuclear Medicine Imaging Agents Sales Market Share, 2018-2029
    4.4 By Type - Global Nuclear Medicine Imaging Agents Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Nuclear Medicine Imaging Agents Market Size, 2022 & 2029
        5.1.2 Early Diagnosis
        5.1.3 Clinical Stage
        5.1.4 Treatment Evaluation
    5.2 By Application - Global Nuclear Medicine Imaging Agents Revenue & Forecasts
        5.2.1 By Application - Global Nuclear Medicine Imaging Agents Revenue, 2018-2023
        5.2.2 By Application - Global Nuclear Medicine Imaging Agents Revenue, 2024-2029
        5.2.3 By Application - Global Nuclear Medicine Imaging Agents Revenue Market Share, 2018-2029
    5.3 By Application - Global Nuclear Medicine Imaging Agents Sales & Forecasts
        5.3.1 By Application - Global Nuclear Medicine Imaging Agents Sales, 2018-2023
        5.3.2 By Application - Global Nuclear Medicine Imaging Agents Sales, 2024-2029
        5.3.3 By Application - Global Nuclear Medicine Imaging Agents Sales Market Share, 2018-2029
    5.4 By Application - Global Nuclear Medicine Imaging Agents Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
    6.1 By Region - Global Nuclear Medicine Imaging Agents Market Size, 2022 & 2029
    6.2 By Region - Global Nuclear Medicine Imaging Agents Revenue & Forecasts
        6.2.1 By Region - Global Nuclear Medicine Imaging Agents Revenue, 2018-2023
        6.2.2 By Region - Global Nuclear Medicine Imaging Agents Revenue, 2024-2029
        6.2.3 By Region - Global Nuclear Medicine Imaging Agents Revenue Market Share, 2018-2029
    6.3 By Region - Global Nuclear Medicine Imaging Agents Sales & Forecasts
        6.3.1 By Region - Global Nuclear Medicine Imaging Agents Sales, 2018-2023
        6.3.2 By Region - Global Nuclear Medicine Imaging Agents Sales, 2024-2029
        6.3.3 By Region - Global Nuclear Medicine Imaging Agents Sales Market Share, 2018-2029
    6.4 North America
        6.4.1 By Country - North America Nuclear Medicine Imaging Agents Revenue, 2018-2029
        6.4.2 By Country - North America Nuclear Medicine Imaging Agents Sales, 2018-2029
        6.4.3 US Nuclear Medicine Imaging Agents Market Size, 2018-2029
        6.4.4 Canada Nuclear Medicine Imaging Agents Market Size, 2018-2029
        6.4.5 Mexico Nuclear Medicine Imaging Agents Market Size, 2018-2029
    6.5 Europe
        6.5.1 By Country - Europe Nuclear Medicine Imaging Agents Revenue, 2018-2029
        6.5.2 By Country - Europe Nuclear Medicine Imaging Agents Sales, 2018-2029
        6.5.3 Germany Nuclear Medicine Imaging Agents Market Size, 2018-2029
        6.5.4 France Nuclear Medicine Imaging Agents Market Size, 2018-2029
        6.5.5 U.K. Nuclear Medicine Imaging Agents Market Size, 2018-2029
        6.5.6 Italy Nuclear Medicine Imaging Agents Market Size, 2018-2029
        6.5.7 Russia Nuclear Medicine Imaging Agents Market Size, 2018-2029
        6.5.8 Nordic Countries Nuclear Medicine Imaging Agents Market Size, 2018-2029
        6.5.9 Benelux Nuclear Medicine Imaging Agents Market Size, 2018-2029
    6.6 Asia
        6.6.1 By Region - Asia Nuclear Medicine Imaging Agents Revenue, 2018-2029
        6.6.2 By Region - Asia Nuclear Medicine Imaging Agents Sales, 2018-2029
        6.6.3 China Nuclear Medicine Imaging Agents Market Size, 2018-2029
        6.6.4 Japan Nuclear Medicine Imaging Agents Market Size, 2018-2029
        6.6.5 South Korea Nuclear Medicine Imaging Agents Market Size, 2018-2029
        6.6.6 Southeast Asia Nuclear Medicine Imaging Agents Market Size, 2018-2029
        6.6.7 India Nuclear Medicine Imaging Agents Market Size, 2018-2029
    6.7 South America
        6.7.1 By Country - South America Nuclear Medicine Imaging Agents Revenue, 2018-2029
        6.7.2 By Country - South America Nuclear Medicine Imaging Agents Sales, 2018-2029
        6.7.3 Brazil Nuclear Medicine Imaging Agents Market Size, 2018-2029
        6.7.4 Argentina Nuclear Medicine Imaging Agents Market Size, 2018-2029
    6.8 Middle East & Africa
        6.8.1 By Country - Middle East & Africa Nuclear Medicine Imaging Agents Revenue, 2018-2029
        6.8.2 By Country - Middle East & Africa Nuclear Medicine Imaging Agents Sales, 2018-2029
        6.8.3 Turkey Nuclear Medicine Imaging Agents Market Size, 2018-2029
        6.8.4 Israel Nuclear Medicine Imaging Agents Market Size, 2018-2029
        6.8.5 Saudi Arabia Nuclear Medicine Imaging Agents Market Size, 2018-2029
        6.8.6 UAE Nuclear Medicine Imaging Agents Market Size, 2018-2029
7 Manufacturers & Brands Profiles
    7.1 GE HealthCare
        7.1.1 GE HealthCare Company Summary
        7.1.2 GE HealthCare Business Overview
        7.1.3 GE HealthCare Nuclear Medicine Imaging Agents Major Product Offerings
        7.1.4 GE HealthCare Nuclear Medicine Imaging Agents Sales and Revenue in Global (2018-2023)
        7.1.5 GE HealthCare Key News & Latest Developments
    7.2 Bracco Diagnostic
        7.2.1 Bracco Diagnostic Company Summary
        7.2.2 Bracco Diagnostic Business Overview
        7.2.3 Bracco Diagnostic Nuclear Medicine Imaging Agents Major Product Offerings
        7.2.4 Bracco Diagnostic Nuclear Medicine Imaging Agents Sales and Revenue in Global (2018-2023)
        7.2.5 Bracco Diagnostic Key News & Latest Developments
    7.3 Guerbet
        7.3.1 Guerbet Company Summary
        7.3.2 Guerbet Business Overview
        7.3.3 Guerbet Nuclear Medicine Imaging Agents Major Product Offerings
        7.3.4 Guerbet Nuclear Medicine Imaging Agents Sales and Revenue in Global (2018-2023)
        7.3.5 Guerbet Key News & Latest Developments
    7.4 Mallinckrodt
        7.4.1 Mallinckrodt Company Summary
        7.4.2 Mallinckrodt Business Overview
        7.4.3 Mallinckrodt Nuclear Medicine Imaging Agents Major Product Offerings
        7.4.4 Mallinckrodt Nuclear Medicine Imaging Agents Sales and Revenue in Global (2018-2023)
        7.4.5 Mallinckrodt Key News & Latest Developments
    7.5 Lantheus
        7.5.1 Lantheus Company Summary
        7.5.2 Lantheus Business Overview
        7.5.3 Lantheus Nuclear Medicine Imaging Agents Major Product Offerings
        7.5.4 Lantheus Nuclear Medicine Imaging Agents Sales and Revenue in Global (2018-2023)
        7.5.5 Lantheus Key News & Latest Developments
    7.6 Yantai Dongcheng
        7.6.1 Yantai Dongcheng Company Summary
        7.6.2 Yantai Dongcheng Business Overview
        7.6.3 Yantai Dongcheng Nuclear Medicine Imaging Agents Major Product Offerings
        7.6.4 Yantai Dongcheng Nuclear Medicine Imaging Agents Sales and Revenue in Global (2018-2023)
        7.6.5 Yantai Dongcheng Key News & Latest Developments
    7.7 Foshan Rui Diao Pharmaceutical
        7.7.1 Foshan Rui Diao Pharmaceutical Company Summary
        7.7.2 Foshan Rui Diao Pharmaceutical Business Overview
        7.7.3 Foshan Rui Diao Pharmaceutical Nuclear Medicine Imaging Agents Major Product Offerings
        7.7.4 Foshan Rui Diao Pharmaceutical Nuclear Medicine Imaging Agents Sales and Revenue in Global (2018-2023)
        7.7.5 Foshan Rui Diao Pharmaceutical Key News & Latest Developments
    7.8 Cardinal Health
        7.8.1 Cardinal Health Company Summary
        7.8.2 Cardinal Health Business Overview
        7.8.3 Cardinal Health Nuclear Medicine Imaging Agents Major Product Offerings
        7.8.4 Cardinal Health Nuclear Medicine Imaging Agents Sales and Revenue in Global (2018-2023)
        7.8.5 Cardinal Health Key News & Latest Developments
    7.9 Blue Earth Diagnostics
        7.9.1 Blue Earth Diagnostics Company Summary
        7.9.2 Blue Earth Diagnostics Business Overview
        7.9.3 Blue Earth Diagnostics Nuclear Medicine Imaging Agents Major Product Offerings
        7.9.4 Blue Earth Diagnostics Nuclear Medicine Imaging Agents Sales and Revenue in Global (2018-2023)
        7.9.5 Blue Earth Diagnostics Key News & Latest Developments
    7.10 Bayer AG
        7.10.1 Bayer AG Company Summary
        7.10.2 Bayer AG Business Overview
        7.10.3 Bayer AG Nuclear Medicine Imaging Agents Major Product Offerings
        7.10.4 Bayer AG Nuclear Medicine Imaging Agents Sales and Revenue in Global (2018-2023)
        7.10.5 Bayer AG Key News & Latest Developments
    7.11 Abx Advanced Biochemical
        7.11.1 Abx Advanced Biochemical Company Summary
        7.11.2 Abx Advanced Biochemical Business Overview
        7.11.3 Abx Advanced Biochemical Nuclear Medicine Imaging Agents Major Product Offerings
        7.11.4 Abx Advanced Biochemical Nuclear Medicine Imaging Agents Sales and Revenue in Global (2018-2023)
        7.11.5 Abx Advanced Biochemical Key News & Latest Developments
    7.12 Eli Lilly and Company
        7.12.1 Eli Lilly and Company Company Summary
        7.12.2 Eli Lilly and Company Business Overview
        7.12.3 Eli Lilly and Company Nuclear Medicine Imaging Agents Major Product Offerings
        7.12.4 Eli Lilly and Company Nuclear Medicine Imaging Agents Sales and Revenue in Global (2018-2023)
        7.12.5 Eli Lilly and Company Key News & Latest Developments
    7.13 Jubilant Pharma Limited
        7.13.1 Jubilant Pharma Limited Company Summary
        7.13.2 Jubilant Pharma Limited Business Overview
        7.13.3 Jubilant Pharma Limited Nuclear Medicine Imaging Agents Major Product Offerings
        7.13.4 Jubilant Pharma Limited Nuclear Medicine Imaging Agents Sales and Revenue in Global (2018-2023)
        7.13.5 Jubilant Pharma Limited Key News & Latest Developments
    7.14 Navidea
        7.14.1 Navidea Company Summary
        7.14.2 Navidea Business Overview
        7.14.3 Navidea Nuclear Medicine Imaging Agents Major Product Offerings
        7.14.4 Navidea Nuclear Medicine Imaging Agents Sales and Revenue in Global (2018-2023)
        7.14.5 Navidea Key News & Latest Developments
8 Global Nuclear Medicine Imaging Agents Production Capacity, Analysis
    8.1 Global Nuclear Medicine Imaging Agents Production Capacity, 2018-2029
    8.2 Nuclear Medicine Imaging Agents Production Capacity of Key Manufacturers in Global Market
    8.3 Global Nuclear Medicine Imaging Agents Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
    9.1 Market Opportunities & Trends
    9.2 Market Drivers
    9.3 Market Restraints
10 Nuclear Medicine Imaging Agents Supply Chain Analysis
    10.1 Nuclear Medicine Imaging Agents Industry Value Chain
    10.2 Nuclear Medicine Imaging Agents Upstream Market
    10.3 Nuclear Medicine Imaging Agents Downstream and Clients
    10.4 Marketing Channels Analysis
        10.4.1 Marketing Channels
        10.4.2 Nuclear Medicine Imaging Agents Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
    12.1 Note
    12.2 Examples of Clients
    12.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Nuclear Medicine Imaging Agents Market, Global Outlook and Forecast 2023-2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?